Deutsche Bank Ag\ Bluebird Bio, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 91,955 shares of BLUE stock, worth $704,375. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,955

Previous 1,173,570 92.16%

Holding current value

$704,375

Previous $1.15 Million 95.91%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$0.47 - $1.35 $508,359 - $1.46 Million	-1,081,615 Reduced 92.16%	91,955 $47,000
Q2 2024 Aug 14, 2024	BUY	$0.85 - $1.26 $376,754 - $558,482	443,240 Added 60.69%	1,173,570 $1.15 Million
Q1 2024 May 15, 2024	BUY	$0.91 - $1.75 $31,290 - $60,173	34,385 Added 4.94%	730,330 $934,000
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $4,044 - $14,799	3,064 Added 0.44%	695,945 $960,000
Q3 2023 Nov 09, 2023	BUY	$3.02 - $4.05 $935,263 - $1.25 Million	309,690 Added 80.82%	692,881 $2.11 Million
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $483,476 - $871,643	173,289 Added 82.56%	383,191 $1.26 Million
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $75,730 - $198,249	24,118 Added 12.98%	209,902 $667,000
Q4 2022 Feb 13, 2023	BUY	$5.77 - $8.49 $890,299 - $1.31 Million	154,298 Added 490.05%	185,784 $1.29 Million
Q3 2022 Nov 14, 2022	SELL	$3.75 - $7.39 $6,903 - $13,604	-1,841 Reduced 5.52%	31,486 $199,000
Q2 2022 Aug 11, 2022	SELL	$2.94 - $5.23 $26,021 - $46,290	-8,851 Reduced 20.98%	33,327 $138,000
Q1 2022 May 13, 2022	SELL	$4.07 - $10.6 $16,780 - $43,703	-4,123 Reduced 8.9%	42,178 $204,000
Q4 2021 Feb 11, 2022	SELL	$8.96 - $16.31 $523,613 - $953,140	-58,439 Reduced 55.79%	46,301 $462,000
Q3 2021 Nov 04, 2021	BUY	$11.24 - $21.0 $527,268 - $985,110	46,910 Added 81.12%	104,740 $2 Million
Q2 2021 Aug 11, 2021	BUY	$18.04 - $22.09 $448,871 - $549,643	24,882 Added 75.52%	57,830 $1.85 Million
Q1 2021 May 13, 2021	SELL	$16.59 - $33.89 $1.28 Million - $2.62 Million	-77,412 Reduced 70.14%	32,948 $643,000
Q4 2020 Feb 16, 2021	SELL	$27.5 - $37.92 $5.73 Million - $7.9 Million	-208,372 Reduced 65.38%	110,360 $4.77 Million
Q3 2020 Nov 12, 2020	SELL	$34.44 - $43.75 $447,892 - $568,968	-13,005 Reduced 3.92%	318,732 $17.2 Million
Q2 2020 Aug 13, 2020	SELL	$27.12 - $45.97 $1.37 Million - $2.32 Million	-50,385 Reduced 13.19%	331,737 $20.3 Million
Q1 2020 May 14, 2020	BUY	$26.16 - $63.5 $1.41 Million - $3.43 Million	53,970 Added 16.45%	382,122 $17.6 Million
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $1.84 Million - $2.42 Million	39,285 Added 13.6%	328,152 $28.8 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $1.13 Million - $1.77 Million	-18,994 Reduced 6.17%	288,867 $26.5 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $2.47 Million - $3.43 Million	32,563 Added 11.83%	307,861 $39.2 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $491,290 - $793,734	7,624 Added 2.85%	275,298 $43.3 Million
Q4 2018 Feb 14, 2019	BUY	$59.1 - $93.26 $377,294 - $595,371	6,384 Added 2.44%	267,674 $26.6 Million
Q3 2018 Dec 21, 2021	BUY	$88.86 - $117.49 $5.55 Million - $7.33 Million	62,419 Added 31.39%	261,290 $38.1 Million
Q3 2018 Nov 14, 2018	SELL	$88.86 - $117.49 $5.84 Million - $7.72 Million	-65,680 Reduced 24.83%	198,871 $29 Million
Q2 2018 Apr 21, 2020	BUY	$99.64 - $127.59 $3.16 Million - $4.05 Million	31,737 Added 13.63%	264,551 $41.5 Million
Q2 2018 Aug 14, 2018	SELL	$99.64 - $127.59 $15.3 Million - $19.6 Million	-153,555 Reduced 39.74%	232,814 $36.5 Million
Q1 2018 Oct 18, 2019	BUY	$105.8 - $150.94 $4.31 Million - $6.15 Million	40,741 Added 11.79%	386,369 $66 Million
Q1 2018 May 15, 2018	SELL	$105.8 - $150.94 $1.93 Million - $2.75 Million	-18,230 Reduced 5.01%	345,628 $59 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $8.59 Million - $13.8 Million	105,755 Added 40.97%	363,858 $64.8 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $14.9 Million - $23.6 Million	258,103	258,103 $35.4 Million

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $591M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account